Consent Forms Forms Jurisdiction Meeting Dates On-Line Resources Policies and Procedures Review Fees Submission Information Translation
Forms

Application to the Board

For New Applications to OHREB, whether they are for full board or expedited review, you will need the following forms:

  • INSTRUCTION SHEET (.doc, .pdf)
  • OHREB Application (.doc, .pdf)
    • Additional Co-Investigators (.doc, .pdf)
  • Genetics Addendum (.doc, .pdf)
  • Departmental Impact (.doc, .pdf)
    • List of departmental contacts (.doc, .pdf)
  • Diagnostic Imaging Impact
    • Diagnostic Imaging
        Research summary (.doc)
        Research summary submission notes (.doc, .pdf)
        Summary cover letter for ethics (.doc)
    • Nuclear Medicine
        Research summary (.doc)
        Research summary submission notes (.doc)
        Summary cover letter for ethics (.doc)
  • Health Records (.pdf)
  • Institute for Rehabilitation Research & Development (IRDD) Impact Form (.doc, .pdf)
  • Nursing (.doc,.pdf)
  • Ophthalmology (Guidelines .pdf, Eye 56 .pdf)
  • Pathology and Laboratory Medicine Impact (.doc, .xls)
  • Pharmacy
    • Studies Fees Memo (.pdf)
    • TOH Pharmacy Trial Fees (.pdf)
    • Request for Pharmacy Services (.doc, .pdf)
  • Radiation Safety and Health Physics Impact
    • Approval flow chart (.pdf)
    • ADM XII 105 Research Projects w-Nuclear Substances or Radiation Emitting Devices Involving HUMANS (.doc, .pdf)
    • Contact Persons Dosimetry Human Studies (.doc, .pdf)
    • Human Studies Submission Cmtee Deadlines (.doc, .pdf)
    • Radiation Dosimetry References Human Studies December (.doc, .pdf)
    • Radiation Safety Form (.doc, .pdf )

Application for Chart Review

Applications for chart review are available for download here and are also available in hard copy in Health Records Service

Study Renewal

To renew your study on an annual basis, you will need to complete and submit the following form 60 days in advance of the approval expiry date. If you have completed research participant enrollment, but research participants remain on follow-up, this form should be completed. If recruitment is still ongoing, submit a copy of the last approved Patient Information Sheet and/or Consent Forms. If they are being revised, attach a copy of the revised documents with all changes highlighted, and a clean final version of the revised document printed on original letterhead. Be sure to update the 'version' and 'date' on the revised form. Please ensure the OHREB's contact phone number is correct. The number is 613-798-5555, extension 14902.

IT IS THE INVESTIGATOR’S RESPONSIBILITY TO ENSURE THAT STUDY APPROVAL DOES NOT LAPSE. PATIENT RECRUITMENT CANNOT CONTINUE IF STUDY APPROVAL LAPSES

Study Termination

If your study is complete, you need to inform us by submitting the following form. Please do not complete this form if patients remain on follow-up (see Annual Renewal Form).

Study Amendments

If there has been an amendment to your study, please complete the following form. Be sure to include the appropriate revised documents. If there are changes required to the Patient Information and Consent Form because of the amendments, include a copy of the revised documents with all changes highlighted, and a clean final version of the revised document printed on original letterhead. Be sure to update the 'version' and 'date' on the revised form.

Adverse Event Reporting

If there are any adverse events (SAEs) to report, please inform the OHREB by using the following form. If there are changes required to the Patient Information and Consent Form because of these adverse events, include a copy of the revised documents with all changes highlighted, and a clean final version of the revised document printed on original letterhead. Be sure to update the 'version' and 'date' on the revised form.